Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
2003 · Leukemia · 730 citations
https://doi.org/10.1038/sj.leu.2402945
L
Linda S. Steelman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
152
Papers
16.3K
Citations
56
h-index
110
i10-index
Linda S. Steelman is an academic researcher. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Melanoma and MAPK Pathways & Cytokine Signaling Pathways and Interactions. The author has an h-index of 56, co-authored 130 publications.
Papers by this author
worksRoles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
2011 · Aging · 686 citations
https://doi.org/10.18632/aging.100296
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
2017 · Aging · 275 citations
https://doi.org/10.18632/aging.101250
Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
2012 · Current Pharmaceutical Design · 44 citations
https://doi.org/10.2174/138161212799859701
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat